Cargando…
Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells – Possible Role of GLUT1 Transporter
PURPOSE: In order to overcome the obstacles and side effects of classical chemotherapy, numerous studies have been performed to develop the treatment based on targeted transport of active compounds directly to the site of action. Since tumor cells are featured with intensified glucose metabolism, we...
Autores principales: | Sztandera, Krzysztof, Działak, Paula, Marcinkowska, Monika, Stańczyk, Maciej, Gorzkiewicz, Michał, Janaszewska, Anna, Klajnert-Maculewicz, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669199/ https://www.ncbi.nlm.nih.gov/pubmed/31367876 http://dx.doi.org/10.1007/s11095-019-2673-9 |
Ejemplares similares
-
Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody
por: Marcinkowska, Monika, et al.
Publicado: (2019) -
Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy
por: Marcinkowska, Monika, et al.
Publicado: (2018) -
Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy
por: Marcinkowska, Monika, et al.
Publicado: (2019) -
Intrinsic Fluorescence of PAMAM Dendrimers—Quenching Studies
por: Konopka, Malgorzata, et al.
Publicado: (2018) -
Mesalazine–PAMAM Nanoparticles for Transporter-Independent Intracellular Drug Delivery: Cellular Uptake and Anti-Inflammatory Activity
por: Gorzkiewicz, Michal, et al.
Publicado: (2023)